by Innophore | Oct 10, 2021 | Awards, News, Print
Press release – Innophore will receive credits and customized expertise from Amazon Web Service (AWS) to develop a new diagnostic tool to track and monitor SARS-CoV-2 variants using structure models. Graz, Austria October 10th, 2021 – Innophore, a pioneering...
by Innophore | Jul 23, 2021 | Awards, Drug Discovery, Media, News, Online, Research
Our VirtualFlow team has made it to the finalist stage for the JEDI Covid-19 GrandChallenge! “An estimated 54 billion molecules were screened by 130 teams representing more than 500 scientists from the world’s top institutions. The VirtualFlow team, consisting of...
by Innophore | Feb 22, 2021 | Drug Discovery, Enzyme Discovery, News, Paper
Our next Covid-19 paper is published as Scientific Reports from the Nature Group https://www.nature.com/articles/s41598-021-83761-5 Abstract: Since the worldwide outbreak of the infectious disease COVID-19, several studies have been published to understand the...
by Innophore | Jan 23, 2020 | Drug Discovery, Enzyme Discovery, Innophore, News, Research
Christian C. Gruber*, Georg Steinkellner Innophore, Am Eisernen Tor 3, 8010 Graz, Austria * chirstian.gruber@innophore.com DISCLAIMER: Permission is hereby granted, free of charge, to any person in academic and/or industrial research and science (independent of their...
by Innophore | Nov 8, 2019 | News
Innophore has put its new remotely operated hydropower data center into operation, deep in the heart of the Austrian Alps. Our existing HPC clusters were expanded by a hyperconverged, private cloud with 1536 computing cores powered sustainably directly by the...
by Innophore | Oct 22, 2019 | Innophore, News, Research
Innophore & SignalChem start partnershipInnophore and SignalChem have agreed to collaborate on Drug & Enzyme Discovery in the future.Innophore’s cutting-edge technology will make it possible to learn from kinase data sets at the...
